Notably, miR-539-5p exhibits potential significance in the pathogenesis of LPS-induced sepsis by selectively targeting IRAK3, suggesting its potential as a therapeutic target for treating LPS-induced sepsis (Hu and Miao, 2022). This evidence concerns the gene IRAK3 and Sepsis.